Nobligan (Tramadol Hydrochloride)

Tramadol Hydrochloride, the active ingredient in Nobligan, is an opioid analgesic presented as a tablet for oral use. It treats moderate to severe acute pain and chronic pain where opioid therapy is appropriate.

GNH USA supplies Nobligan as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Tramadol Hydrochloride is an opioid analgesic used to manage pain in several clinical contexts. - Moderate to severe acute pain: provides effective relief for postoperative or injury‑related pain. - Chronic pain where opioid therapy is appropriate: helps control long‑term pain when other treatments are insufficient. - Cancer‑related pain: used as part of a multimodal regimen for cancer patients requiring opioid analgesia.

Tramadol Hydrochloride may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Dizziness: feeling light‑headed or unsteady. - Constipation: reduced bowel movements. - Headache: mild to moderate pain in the head. - Somnolence: increased sleepiness or fatigue. - Dry mouth: reduced salivation.

Serious or Rare Side Effects: - Respiratory depression: slowed breathing, potentially life‑threatening. - Seizures: risk increased at high doses or with interacting drugs. - Serotonin syndrome: agitation, hyperthermia, and neuromuscular abnormalities. - Severe allergic reactions: rash, swelling, or anaphylaxis. - Hypotension: marked drop in blood pressure. - Cardiac arrhythmia: irregular heart rhythm.

When prescribing Tramadol Hydrochloride, clinicians should consider several safety measures. - Assess pain severity and opioid suitability: evaluate patient before initiating therapy. - Monitor for signs of dependence or abuse: conduct regular assessments. - Avoid use in patients with severe respiratory depression: contraindicated. - Caution in renal or hepatic impairment: dose adjustment may be required. - Use the lowest effective dose for the shortest duration: follow prescribing guidelines. - Store at ambient temperature: keep in the original pack, protect from moisture.

Tramadol Hydrochloride can interact with other medicines, requiring careful management.

Major Interactions (Avoid): - MAO inhibitors: risk of serotonin syndrome. - SSRIs/SNRIs: increased serotonin syndrome risk. - CNS depressants (benzodiazepines, alcohol): enhanced respiratory depression.

Moderate Interactions (Monitor Closely): - CYP2D6 inhibitors (e.g., fluoxetine): may raise tramadol plasma levels. - CYP3A4 inducers (e.g., rifampin): may lower tramadol effectiveness.